Loading...
HSChapter 29
U.S. exports of ergometrine and its salts (HS 293961) totaled $3K in January 2026, traded with 1 country.
Ergometrine (also known as ergonovine) is an ergot alkaloid used clinically to prevent and treat postpartum hemorrhage, making it a critical obstetric pharmaceutical. As a controlled substance precursor in many jurisdictions, imports of ergometrine and its salts require DEA registration and import permits in addition to standard FDA admissibility review. Classification falls under a single 10-digit line (2939610000), and the narrow therapeutic application means trade volumes are modest but supply continuity is clinically significant. Importers should verify both DEA Schedule status and FDA drug establishment registration before shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
Yes. Ergometrine is classified as a List I chemical precursor by the DEA because of its potential use in illicit drug synthesis. Importers must hold a valid DEA registration and obtain import permits prior to shipment, in addition to meeting FDA's drug admissibility requirements.
The US tariff schedule carves out ergometrine (2939610000), ergotamine (2939620000), and lysergic acid (2939630000) as separate named lines within the ergot alkaloid group. Correct classification depends on the specific compound's identity; mixtures or derivatives not meeting the named-compound definition fall to the NESOI line for ergot alkaloids.
No historical data available for this product yet.
Supplier Network
Get discovered by U.S. importers searching for HS 293961 — Ergometrine and Its Salts. Be the first supplier listed.
NUCLEIC ACIDS & SALTS; OTHER HETEROCYCLIC CMP, NES
HS 293499
POLYPEPTIDE PROTEIN& GLYCOPROTEIN HORMONES &DERIV
HS 293719
CMPDS CONT AN UNFUSED PYRIDINE RING ETC NESOI
HS 293339
BENZENE
HS 290220
HETEROCYCLIC COMP W NITROGEN HETERO-ATM ONLY NESOI
HS 293399
HETEROCYCLIC COMP WITH UNFUSED PYRAZOLE RING NESOI
HS 293319
| Port | Imports | Exports | Balance |
|---|---|---|---|
| WASHINGTON, DC | -- | -- | -- |